4.8 Article

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism

Journal

JOURNAL OF HEPATOLOGY
Volume 57, Issue 1, Pages 150-156

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2012.02.027

Keywords

Hypothyroidism; Non-alcoholic fatty liver disease; Metabolic syndrome; Hepatic steatosis

Funding

  1. Seoul National University Hospital [04-2010-104]

Ask authors/readers for more resources

Background & Aims: The aim of this study was to characterize the relationship between the broad spectrum of hypothyroidism and NAFLD. Methods: A cross-sectional study with 4648 health check-up subjects (2324 cases with hypothyroidism vs. age- and sex-matched controls) was conducted. The subjects were categorized as having either subclinical [thyroid-stimulating hormone (TSH) >= 4.1 mIU/L and normal free thyroixine (T-4) level (0.7-1.8 ng/dl)] or overt hypothyroidism [free T-4 < 0.7 ng/dl]. NAFLD was diagnosed on the basis of typical ultrasonographic findings, and alcohol consumption of less than 20 g/day in the absence of other causes of liver disease. Results: The mean age of the subjects was 48.6 +/- 11.8 years and 62.4% were female. NAFLD was significantly associated with hypothyroidism (30.2% patients vs. 19.5% control, p<0.001). The prevalence of NAFLD and abnormal liver enzyme levels (ALT > 33/25 IU/L) increased steadily with increasing grades of hypothyroidism (for NAFLD, subclinical: 29.9% and overt: 36.3%; for abnormal ALT, 20.1% and 25.9%, p < 0.001, respectively). Multivariate regression analysis showed that NAFLD was statistically significantly associated with hypothyroidism (odds ratio (OR) 1.38, 95% confidence interval (CI), 1.17-1.62) and the grade of hypothyroidism in a dose-dependent manner (OR 1.36, 95% CI, 1.16-1.61 in subclinical hypothyroidism and OR 1.71, 95% CI, 1.10-2.66 in overt hypothyroidism). Conclusions: Subclinical hypothyroidism, even in the range of upper normal TSH levels, was found to be related to NAFLD in a dose-dependent manner. Hypothyroidism is closely associated with NAFLD independently of known metabolic risk factors, confirming a relevant clinical relationship between these two diseases. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available